Cargando…
Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
Alzheimer’s disease (AD) is recognized as a major health hazard that mostly affects people older than 60 years. AD is one of the biggest medical, economic, and social concerns to patients and their caregivers. AD was ranked as the 5(th) leading cause of global deaths in 2016 by the World Health Orga...
Autores principales: | Husna Ibrahim, Nurul, Yahaya, Mohamad Fairuz, Mohamed, Wael, Teoh, Seong Lin, Hui, Chua Kien, Kumar, Jaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105678/ https://www.ncbi.nlm.nih.gov/pubmed/32265696 http://dx.doi.org/10.3389/fphar.2020.00261 |
Ejemplares similares
-
Honey and Alzheimer’s Disease—Current Understanding and Future Prospects
por: Shaikh, Ammara, et al.
Publicado: (2023) -
Targeting dopamine transporter to ameliorate cognitive deficits in Alzheimer's disease
por: Shaikh, Ammara, et al.
Publicado: (2023) -
Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail
por: Hazani, Hanis Mohammad, et al.
Publicado: (2022) -
Sleep Related Epilepsy and Pharmacotherapy: An Insight
por: Kumar, Jaya, et al.
Publicado: (2018) -
Abelmoschus Esculentus (L.) Moench’s Peel Powder Improves High-Fat-Diet-Induced Cognitive Impairment in C57BL/6J Mice
por: Prom-in, Supattra, et al.
Publicado: (2020)